Mainstay Medical applies for CE mark for ReActiv8
Mainstay Medical said it has submitted an application for the CE mark for its back pain treatment
Mainstay Medical said it has submitted an application for the CE mark for ReActiv8, its implantable neurostimulation system to treat chronic lower back pain, a further step toward the commercialisation of the product in Europe.
The company said clinical trials of ReActiv8 showed " clinically important, statistically significant and lasting improvement in pain, disability and quality of life for people with chronic low back pain and limited treatment options".
Mainstay plans to establish ...